4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View 4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	E2F2 Gene (Entity type)	-0.026860597
Crenolanib Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine Compound (Entity type)	0.2729881107807159
4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	TGF-beta RI kinase inhibitor Compound (Entity type)	0.3579794764518738
4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	SLC38A1 Gene (Entity type)	0.021418536
4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	VEGFA Gene (Entity type)	-0.026467912
4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	CFD Gene (Entity type)	0.018261263
4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	IGFBP5 Gene (Entity type)	-0.021034181
4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	CASP2 Gene (Entity type)	0.017801335
4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	TFF3 Gene (Entity type)	-0.029389398
4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	HSPA8 Gene (Entity type)	0.018634167

4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
E2F2
Gene (Entity type)
-0.026860597

Crenolanib
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine
Compound (Entity type)
0.2729881107807159

4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
TGF-beta RI kinase inhibitor
Compound (Entity type)
0.3579794764518738

4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
SLC38A1
Gene (Entity type)
0.021418536

4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
VEGFA
Gene (Entity type)
-0.026467912

4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
CFD
Gene (Entity type)
0.018261263

4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
IGFBP5
Gene (Entity type)
-0.021034181

4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
CASP2
Gene (Entity type)
0.017801335

4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
TFF3
Gene (Entity type)
-0.029389398

4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
HSPA8
Gene (Entity type)
0.018634167

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.